The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 16, 2020

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions

Colonic NeoplasmsChemotherapy Effect

Interventions

DRUG

Anti-PD-1 Monoclonal Antibody JS001

Anti-PD-1 monoclonal antibody combined with chemotherapy in patients with locally advanced colon cancer (perioperative treatment)

DRUG

Chemotherapy

Folfox

Trial Locations (1)

RECRUITING

Shan Zeng, Changsha

All Listed Sponsors

lead

Xiangya Hospital of Central South University

OTHER